Silence Therapeutics (SLN) Free Cash Flow (2024 - 2026)
Silence Therapeutics (SLN) free cash flow from Mar 31, 2024 to Mar 31, 2026. The TTM Silence Therapeutics (SLN) free cash flow is -$66M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Silence Therapeutics (SLN) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -7.62% |
Annual Free Cash Flow change of Silence Therapeutics (SLN)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$16M | -74.97% |
| 2025 | -$62M | -8.14% |
| 2024 | -$68M | +37.02% |
| 2023 | -$50M | -13.44% |
| 2022 | -$57M | -940.09% |
| 2021 | $6.81M | -163.17% |
| 2020 | -$11M | -723.12% |
| 2019 | $1.73M | -110.32% |
| 2018 | -$17M | N/A |